Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Mater Sci Mater Med ; 29(8): 130, 2018 Aug 03.
Artigo em Inglês | MEDLINE | ID: mdl-30074096

RESUMO

The development of a myriad of nanoparticles types has opened new possibilities for the diagnostics and treatment of many diseases, especially for cancer. However, most of the researches done so far do not focus on the protection of normal cells surrounding a tumor from irradiation bystander effects that might lead to cancer recurrence. Gap-junctions are known to be involved in this process, which leads to genomic instability of neighboring normal cells, and flufenamic acid (FFA) is included in a new group of gap-junction blockers recently discovered. The present work explores the use of mesoporous silica nanoparticles MCM-41 functionalized with 3-Aminopropyltriethoxysilane (APTES) for anchoring the flufenamic acid for its prolonged and controlled release and protection from radiation bystander effects. MCM-41 and functionalized samples were structurally and chemically characterized with multiple techniques. The biocompatibility of all samples was tested in a live/dead assay performed in cultured MRC-5 and HeLa cells. HeLa cells cultured were exposed to 50 Gy of gamma-rays and the media transferred to fibroblast cells cultured separately. Our results show that MCM-41 and functionalized samples have high biocompatibility with MCR-5 and HeLa cells, and most importantly, the FFA delivered by these NPs was able to halt apoptosis, one of main bystander effects.


Assuntos
Efeito Espectador/efeitos da radiação , Ácido Flufenâmico/química , Ácido Flufenâmico/farmacologia , Nanopartículas/química , Dióxido de Silício/química , Dióxido de Silício/farmacologia , Efeito Espectador/efeitos dos fármacos , Linhagem Celular , Fibroblastos/efeitos dos fármacos , Fibroblastos/efeitos da radiação , Raios gama/efeitos adversos , Humanos , Teste de Materiais , Microscopia Eletrônica de Varredura
2.
PLoS One ; 10(6): e0128922, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26067671

RESUMO

Glioblastoma (GBM) is an infiltrative tumor that is difficult to eradicate. Treating GBM with mesenchymal stem cells (MSCs) that have been modified with the HSV-Tk suicide gene has brought significant advances mainly because MSCs are chemoattracted to GBM and kill tumor cells via a bystander effect. To use this strategy, abundantly present adipose-tissue-derived mesenchymal stem cells (AT-MSCs) were evaluated for the treatment of GBM in mice. AT-MSCs were prepared using a mechanical protocol to avoid contamination with animal protein and transduced with HSV-Tk via a lentiviral vector. The U-87 glioblastoma cells cultured with AT-MSC-HSV-Tk died in the presence of 25 or 50 µM ganciclovir (GCV). U-87 glioblastoma cells injected into the brains of nude mice generated tumors larger than 3.5 mm2 after 4 weeks, but the injection of AT-MSC-HSV-Tk cells one week after the U-87 injection, combined with GCV treatment, drastically reduced tumors to smaller than 0.5 mm2. Immunohistochemical analysis of the tumors showed the presence of AT-MSC-HSV-Tk cells only within the tumor and its vicinity, but not in other areas of the brain, showing chemoattraction between them. The abundance of AT-MSCs and the easier to obtain them mechanically are strong advantages when compared to using MSCs from other tissues.


Assuntos
Tecido Adiposo/metabolismo , Glioblastoma/metabolismo , Células-Tronco Mesenquimais/enzimologia , Simplexvirus/genética , Timidina Quinase/biossíntese , Transdução Genética , Proteínas Virais/biossíntese , Tecido Adiposo/patologia , Animais , Efeito Espectador/efeitos dos fármacos , Linhagem Celular Tumoral , Feminino , Ganciclovir/farmacologia , Glioblastoma/patologia , Glioblastoma/terapia , Humanos , Células-Tronco Mesenquimais/patologia , Camundongos , Camundongos Nus , Simplexvirus/enzimologia , Timidina Quinase/genética , Proteínas Virais/genética
3.
Cancer Gene Ther ; 11(5): 333-45, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15107812

RESUMO

We have developed multicellular spheroids (MCS) established from LM05e and LM3 spontaneous Balb/c-murine mammary adenocarcinoma and B16 C57-murine melanoma derived cell lines as an in vitro model to study the efficacy of the herpes simplex virus thymidine kinase/ganciclovir (HSVtk/GCV) suicide system. We demonstrated for the first time that HSVtk-expressing cells assembled as MCS manifested a GCV resistance phenotype compared to the same cells grown as sparse monolayers. HSVtk-expressing LM05e, LM3 and B16 spheroids were 16-, three- and nine-fold less sensitive to GCV than their respective monolayers, even though they could express transgenes 10-, eight- and five-fold more efficiently. Mixed populations of HSVtk- and their respective beta gal-expressing cells displayed a cell-type specific bystander effect that was higher in monolayers than in MCS. However, HSVtk-expressing cells in two- or three-dimensional cultures were always significantly more sensitive to GCV than the beta gal-expressing counterparts, supporting the feasibility of this suicide approach in vivo. We present evidence showing that HSVtk-expressing tumor cells, when transferred from monolayers to MCS, displayed: (i) lower GCV cytotoxic activity and bystander effect; (ii) higher and efficient expression of genes transferred as lipoplexes; (iii) lower cell proliferation rates; and (iv) changes in intracellular Bax/Bcl-xL rheostat of mitochondria-mediated apoptosis.


Assuntos
Adenocarcinoma/terapia , Antivirais/farmacologia , Ganciclovir/farmacologia , Neoplasias Mamárias Animais/terapia , Timidina Quinase/genética , Proteínas Virais/genética , Adenocarcinoma/genética , Adenocarcinoma/patologia , Adenocarcinoma/virologia , Animais , Efeito Espectador/efeitos dos fármacos , Efeito Espectador/genética , Efeito Espectador/fisiologia , Divisão Celular/efeitos dos fármacos , Divisão Celular/genética , Linhagem Celular Tumoral , Resistência a Medicamentos/genética , Resistência a Medicamentos/fisiologia , Terapia Genética , Neoplasias Mamárias Animais/genética , Neoplasias Mamárias Animais/patologia , Neoplasias Mamárias Animais/virologia , Melanoma/genética , Melanoma/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Proteínas Proto-Oncogênicas c-bcl-2 , Simplexvirus/enzimologia , Simplexvirus/genética , Esferoides Celulares/efeitos dos fármacos , Esferoides Celulares/enzimologia , Esferoides Celulares/patologia , Timidina Quinase/metabolismo , Transfecção , Proteínas Virais/metabolismo , Proteína X Associada a bcl-2 , beta-Galactosidase/genética , beta-Galactosidase/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA